Royal Bank of Canada’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $28.9M | Sell |
319,726
-86,837
| -21% | -$7.97M | 0.01% | 1208 |
|
|
2025
Q4 | $36.6M | Sell |
406,563
-999,524
| -71% | -$94.8M | 0.01% | 1102 |
|
|
2025
Q3 | $139M | Buy |
1,406,087
+377,965
| +37% | +$37.5M | 0.02% | 551 |
|
|
2025
Q2 | $93.8M | Buy |
1,028,122
+606,900
| +144% | +$58.7M | 0.02% | 647 |
|
|
2025
Q1 | $47.7M | Buy |
421,222
+73,296
| +21% | +$7.84M | 0.01% | 818 |
|
|
2024
Q4 | $36.8M | Buy |
347,926
+139,959
| +67% | +$15M | 0.01% | 985 |
|
|
2024
Q3 | $22.5M | Sell |
207,967
-8,211
| -4% | -$896K | ﹤0.01% | 1276 |
|
|
2024
Q2 | $23.5M | Buy |
216,178
+8,595
| +4% | +$1.01M | 0.01% | 1162 |
|
|
2024
Q1 | $27.4M | Sell |
207,583
-54,065
| -21% | -$6.75M | 0.01% | 1085 |
|
|
2023
Q4 | $31.8M | Buy |
261,648
+330
| +0.1% | +$36.8K | 0.01% | 999 |
|
|
2023
Q3 | $29.3M | Sell |
261,318
-70,737
| -21% | -$8.98M | 0.01% | 959 |
|
|
2023
Q2 | $48.3M | Buy |
332,055
+28,730
| +9% | +$3.9M | 0.01% | 715 |
|
|
2023
Q1 | $39.2M | Sell |
303,325
-10,566
| -3% | -$1.33M | 0.01% | 785 |
|
|
2022
Q4 | $40M | Buy |
313,891
+31,052
| +11% | +$3.6M | 0.01% | 763 |
|
|
2022
Q3 | $29.6M | Sell |
282,839
-63,827
| -18% | -$7M | 0.01% | 851 |
|
|
2022
Q2 | $36.4M | Sell |
346,666
-18,627
| -5% | -$2.21M | 0.01% | 793 |
|
|
2022
Q1 | $46.7M | Sell |
365,293
-162,547
| -31% | -$19.6M | 0.01% | 769 |
|
|
2021
Q4 | $65.1M | Sell |
527,840
-4,311
| -0.8% | -$564K | 0.01% | 702 |
|
|
2021
Q3 | $75.6M | Sell |
532,151
-252,974
| -32% | -$37.2M | 0.02% | 594 |
|
|
2021
Q2 | $123M | Buy |
785,125
+42,480
| +6% | +$6.88M | 0.03% | 433 |
|
|
2021
Q1 | $115M | Sell |
742,645
-11,947
| -2% | -$1.85M | 0.03% | 418 |
|
|
2020
Q4 | $113M | Buy |
754,592
+110,828
| +17% | +$15.7M | 0.03% | 420 |
|
|
2020
Q3 | $85.1M | Buy |
643,764
+56,920
| +10% | +$7.44M | 0.03% | 436 |
|
|
2020
Q2 | $68M | Sell |
586,844
-55,991
| -9% | -$6.45M | 0.03% | 472 |
|
|
2020
Q1 | $63.1M | Buy |
642,835
+76,369
| +13% | +$10M | 0.03% | 430 |
|
|
2019
Q4 | $82.3M | Sell |
566,466
-9,383
| -2% | -$1.3M | 0.03% | 439 |
|
|
2019
Q3 | $76.7M | Buy |
575,849
+246,731
| +75% | +$31.9M | 0.03% | 442 |
|
|
2019
Q2 | $37.6M | Sell |
329,118
-1,655
| -0.5% | -$194K | 0.02% | 720 |
|
|
2019
Q1 | $41M | Sell |
330,773
-13,316
| -4% | -$1.51M | 0.02% | 651 |
|
|
2018
Q4 | $34.6M | Sell |
344,089
-52,196
| -13% | -$5.87M | 0.02% | 686 |
|
|
2018
Q3 | $50.6M | Buy |
396,285
+2,247
| +0.6% | +$267K | 0.02% | 583 |
|
|
2018
Q2 | $42.6M | Sell |
394,038
-5,400
| -1% | -$588K | 0.02% | 635 |
|
|
2018
Q1 | $42.3M | Sell |
399,438
-9,927
| -2% | -$1.15M | 0.02% | 659 |
|
|
2017
Q4 | $48M | Buy |
409,365
+39,663
| +11% | +$4.49M | 0.02% | 627 |
|
|
2017
Q3 | $42M | Buy |
369,702
+22,528
| +6% | +$2.6M | 0.02% | 652 |
|
|
2017
Q2 | $43.3M | Buy |
347,174
+28,023
| +9% | +$3.32M | 0.02% | 607 |
|
|
2017
Q1 | $37.8M | Buy |
319,151
+98,343
| +45% | +$11.1M | 0.02% | 653 |
|
|
2016
Q4 | $22.1M | Buy |
220,808
+34,044
| +18% | +$3.65M | 0.01% | 997 |
|
|
2016
Q3 | $23.6M | Buy |
186,764
+10,911
| +6% | +$1.35M | 0.01% | 903 |
|
|
2016
Q2 | $20.6M | Sell |
175,853
-778
| -0.4% | -$88K | 0.01% | 943 |
|
|
2016
Q1 | $18.3M | Sell |
176,631
-10,383
| -6% | -$1M | 0.01% | 982 |
|
|
2015
Q4 | $18.6M | Buy |
187,014
+22,544
| +14% | +$2.21M | 0.01% | 1018 |
|
|
2015
Q3 | $15M | Buy |
164,470
+45,106
| +38% | +$4.52M | 0.01% | 926 |
|
|
2015
Q2 | $12.7M | Buy |
119,364
+13,089
| +12% | +$1.45M | 0.01% | 1083 |
|
|
2015
Q1 | $12.1M | Sell |
106,275
-196,189
| -65% | -$22.4M | 0.01% | 1101 |
|
|
2014
Q4 | $33.3M | Buy |
302,464
+184,127
| +156% | +$19.4M | 0.02% | 587 |
|
|
2014
Q3 | $11.6M | Sell |
118,337
-6,166
| -5% | -$606K | 0.01% | 1120 |
|
|
2014
Q2 | $12.6M | Sell |
124,503
-6,872
| -5% | -$671K | 0.01% | 1080 |
|
|
2014
Q1 | $12.1M | Sell |
131,375
-33,265
| -20% | -$3.07M | 0.01% | 1044 |
|
|
2013
Q4 | $14.9M | Buy |
164,640
+15,061
| +10% | +$1.3M | 0.01% | 954 |
|
|
2013
Q3 | $11.9M | Sell |
149,579
-141,843
| -49% | -$11.2M | 0.01% | 1044 |
|
|
2013
Q2 | $21.2M | Buy |
+291,422
| New | +$21.8M | 0.02% | 624 |
|
Other funds holding ZBH
VCM
VPM
Royal Bank of Canada's ZBH Position: Q1 2026 in Review
Royal Bank of Canada reduced its Zimmer Biomet (ZBH) stake by 21% in Q1 2026, selling an estimated $7.97M and leaving 319,726 shares worth $28.9M. The position accounts for 0.01% of the portfolio, ranked #1208.
Royal Bank of Canada first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $139M in Q3 2025. 914 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Royal Bank of Canada held 319,726 shares of Zimmer Biomet worth $28.9M as of Q1 2026.
- Royal Bank of Canada sold 86,837 Zimmer Biomet shares in Q1 2026, an estimated $7.97M.
- Zimmer Biomet made up 0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #1208 holding.
- Royal Bank of Canada first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
- Royal Bank of Canada's Zimmer Biomet position peaked at $139M in Q3 2025.
- 914 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.